Effect on Treatment Burden Post - Versus Pre-Iluvien Based on Prior DME Treatments

Related

• 

  Argus II Retinal Prosthesis Complication Profile Pre- and Post-FDA Approval

  Aleksandra V. Rachitskaya, MD, FASRS

  Annual Meeting Talks

  2018

• 

  Structural Outcomes and Imaging Observations Following Scleral Window to Treat Exudative Detachment in Uveal Effusion Syndrome

  Prithvi Mruthyunjaya, MD, MHS

  Annual Meeting Talks

  2018

• 

  Part 3: Implementing Clinical Trials in a Retina Practice: How to Get Started and Recruit Successfully (Part 3 of 3)

  Arshad M. Khanani, MD, MA, FASRS

  Carl J Danzig, MD

  Charles C Wykoff, MD, PhD, FASRS

  John D Pitcher, MD

  Nikolas JS London, MD, FACS, FASRS

  On Demand Cases, Courses, and Papers

  2018